계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Abcam
company
About
An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.
- 1001 - 5000
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- £200M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 1998
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
As an innovator in reagents and tools, our purpose is to serve life science researchers globally to achieve their mission, faster. Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers and assays.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£200M
Abcam has raised a total of
£200M
in funding over 2 rounds. Their latest funding was raised on
May 15, 2019 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 15, 2019 | Post-IPO Equity | £200M | 1 |
HSBC
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Abcam has made 2 investments. Their most recent investment was on
Jul 10, 2014, when Button raised $2.25M.
Investors
Number of Lead Investors
Number of Investors
1
1
Abcam is funded by 1 investors.
HSBC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
HSBC
|
Yes | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
